UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis

Journal of dermatological science, 2016-03, Vol.81 (3), p.153-164

2016

Volltextzugriff (PDF)

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

Journal of the American Academy of Dermatology, 2021-07, Vol.85 (1), p.71-78

2021

Volltextzugriff (PDF)

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

Allergy (Copenhagen), 2022-08, Vol.77 (8), p.2555-2558

2022

Volltextzugriff (PDF)

Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis

British journal of dermatology (1951), 2023-01, Vol.188 (1), p.146-148

2023

Volltextzugriff (PDF)

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

Journal of dermatological science, 2014-08, Vol.75 (2), p.133-139

2014

Volltextzugriff (PDF)

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis—A randomized controlled study

Allergy (Copenhagen), 2023-07, Vol.78 (7), p.1964-1979

2023

Volltextzugriff (PDF)

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.3335-3337.e1

2022

Volltextzugriff (PDF)

Skin and systemic inflammation in adults with atopic dermatitis before and after whole‐body topical betamethasone 17‐valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Journal of the European Academy of Dermatology and Venereology, 2024-07

2024

Volltextzugriff (PDF)

Multispectral imaging of hand eczema

Contact dermatitis, 2019-12, Vol.81 (6), p.438-445

2019

Volltextzugriff (PDF)

Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis

Experimental dermatology, 2015-03, Vol.24 (3), p.187-193

2015

Volltextzugriff (PDF)

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

Journal of the American Academy of Dermatology, 2023-04, Vol.88 (4), p.816-823

2023

Volltextzugriff (PDF)

The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis

Journal of drugs in dermatology, 2013-08, Vol.12 (8), p.e129

2013

Volltextzugriff (PDF)

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

Journal of dermatological science, 2017-02, Vol.85 (2), p.147-147

2017

Volltextzugriff (PDF)

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma

Anticancer research, 2014-12, Vol.34 (12), p.7207-7217

2014

Volltextzugriff (PDF)

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Leukemia & lymphoma, 2014-04, Vol.55 (4), p.957-958

2014

Volltextzugriff (PDF)

Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

Dermatitis, 2015-07, Vol.26 (4), p.195

2015

Volltextzugriff (PDF)

Non‐invasive assessment of soluble skin surface biomarkers in atopic dermatitis patients—Effect of treatment

Skin research and technology, 2021-09, Vol.27 (5), p.715-722

2021

Volltextzugriff (PDF)

The gene expression and immunohistochemical time‐course of diphenylcyclopropenone‐induced contact allergy in healthy humans following repeated epicutaneous challenges

Experimental dermatology, 2017-10, Vol.26 (10), p.926-933

2017

Volltextzugriff (PDF)

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB198-AB198

2023

Volltextzugriff (PDF)

Objective Quantification of Immune Cell Infiltrates and Epidermal Proliferation in Psoriatic Skin: A Comparison of Digital Image Analysis and Manual Counting

Applied immunohistochemistry & molecular morphology, 2016-07, Vol.24 (6), p.453

2016

Volltextzugriff (PDF)

40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB241-AB241

2023

Volltextzugriff (PDF)

43966 Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis

Journal of the American Academy of Dermatology, 2023-09, Vol.89 (3), p.AB92-AB92

2023

Volltextzugriff (PDF)

Psoriasis drug discovery: methods for evaluation of potential drug candidates

Expert opinion on drug discovery, 2012-01, Vol.7 (1), p.49-61

2012

Volltextzugriff (PDF)

28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

Journal of the American Academy of Dermatology, 2021-09, Vol.85 (3), p.AB177-AB177

2021

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Aktive Filter

ThemaSkin - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(35)

Publikationsform

Sprache

Englisch
(43)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell–Th17 cell axis in psoriasis

Tralokinumab does not impact vaccine-induced immune responses: Results from a 30-week, randomized, placebo-controlled trial in adults with moderate-to-severe atopic dermatitis

IL‐4 and IL‐13 both contribute to the homeostasis of human conjunctival goblet cells in vitro

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)

Interleukin-13 inhibition by tralokinumab reduces inducible T-cell costimulator-positive innate lymphoid cells in skin lesions of atopic dermatitis

MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis

Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis—A randomized controlled study

EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab

Skin and systemic inflammation in adults with atopic dermatitis before and after whole‐body topical betamethasone 17‐valerate 0.1% or tacrolimus 0.1% treatment: A randomized controlled study

Multispectral imaging of hand eczema

Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic skin that reflect systemic microRNA changes in psoriasis

Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial

The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis

Corrigendum to “Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis” [J. Dermatol. Sci. 81 (2016) 153–164]

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Allergic contact dermatitis to nickel is characterized by a specific micro-RNA signature

Non‐invasive assessment of soluble skin surface biomarkers in atopic dermatitis patients—Effect of treatment

The gene expression and immunohistochemical time‐course of diphenylcyclopropenone‐induced contact allergy in healthy humans following repeated epicutaneous challenges

43946 Neutralization of IL-13 by tralokinumab improves atopic dermatitis endotypes characterized by S. aureus colonization

Objective Quantification of Immune Cell Infiltrates and Epidermal Proliferation in Psoriatic Skin: A Comparison of Digital Image Analysis and Manual Counting

40900 Tralokinumab modulates the transcriptomic profile of lesional and non-lesional skin in adolescents with moderate-to-severe atopic dermatitis assessed by tape-stripping

43966 Targeting interleukin-13 with tralokinumab reduces S. aureus abundance in adolescents with atopic dermatitis

Psoriasis drug discovery: methods for evaluation of potential drug candidates

28170 Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis

Aktive Filter

Suchergebnisse filtern